Top Market Players in Global Artificial Intelligence in Precision Medicine Market
Introduction
Healthcare has become one of the largest sectors, both in terms of revenue and employment. In terms of spending, health spendings are transitioning globally with rise in domestics spending. As per The Economist Intelligence Unit (EIU), Global healthcare spending will rise by 4.1%, year on year, in 2022 as countries rise to the diverse challenges of coronavirus and non-coronavirus care. It will be among the fastest growth rates for a decade. Moreover, as a share of global GDP, healthcare spending will remain at 10.5%, up from 10.2% in 2019. Likewise, A report provided by World Health Organization, Global expenditure on health has doubled in real terms and reached to US$8.5 trillion in 2019 and 9.8% of GDP. High income countries accounted for nearly 80% of global spending on health (with the United States of America alone accounting for more than 40%), and their average spending per capita was more than four times the average GDP per capita of low-income countries.
Market Analysis
Artificial Intelligence (AI) has emerged as a transformative force in healthcare, particularly in the field of precision medicine. Precision medicine, also known as personalized medicine, aims to tailor medical treatment and interventions to individual patients based on their genetic makeup, lifestyle, and specific disease characteristics. Precision medicine represents a paradigm shift in healthcare, moving away from the traditional "one-size-fits-all" approach to treatment. Its core objective is to customize medical care for each patient, accounting for genetic variations, environmental factors, and lifestyle choices. By doing so, precision medicine seeks to enhance treatment outcomes, minimize adverse effects, and optimize healthcare resources.
One prominent application of AI in precision medicine is in the field of genomics. AI algorithms analyze vast genomic datasets to identify genetic variations associated with diseases. Also, it plays a crucial role in precision oncology, medical images such as MRIs, CT scans, and pathology slides. The application of AI in precision medicine is poised to revolutionize healthcare. As AI algorithms become more sophisticated and data sources continue to expand, the precision medicine landscape will evolve rapidly.
The growing availability of extensive and diverse healthcare data is a pivotal driver behind the advancement of Artificial Intelligence (AI) in precision medicine. This data encompasses a wide spectrum, including the complete genetic information of individuals (genomics), comprehensive electronic health records (EHRs) documenting their medical histories, intricate medical imaging such as MRIs and CT scans, and real-time health data collected through wearable sensors. For example, as of 2021, nearly 9 in 10 (88%) of U.S. office-based physicians adopted any electronic health record (EHR), and nearly 4 in 5 (78%) had adopted a certified HER.
North America attracts significant investments in AI startups and healthcare technology ventures. In the context of AI industry, USA hold the highest share with more than 50% AI companies located in country, followed by UK with 15%, Europe with 14% shares. Thus, the AI industry is penetrated in this region. Venture capital firms and government initiatives allocate substantial funds to accelerate AI research, development, and implementation in precision medicine. For example, IN the North America Health Tech 200 is focused on identifying young, fast growing, and innovative health, biotech and medtech start-ups in Canada and the United States.
Market Players in Artifcial Intelligence in Precision Medicine Market
Google Cloud, a subsidiary of Alphabet Inc., is a prominent player in the cloud computing and technology services industry. It offers a comprehensive suite of cloud-based solutions and services tailored to meet the evolving needs of businesses across the globe. At its core, Google Cloud provides cloud infrastructure and platform services, including computing power, data storage, and networking resources, to help organizations scale their operations efficiently. These services are hosted on Google's extensive and robust global network of data centers, ensuring high availability and reliability.
NVIDIA Corporation, headquartered in Santa Clara, California, is a global technology leader renowned for its pioneering work in graphics processing units (GPUs) and high-performance computing. Founded in 1993, NVIDIA has evolved from its origins in gaming graphics to become a key player in various industries, including artificial intelligence, autonomous vehicles, data centers, and gaming.
The company's GPUs are at the heart of cutting-edge technologies, powering supercomputers, deep learning systems, and advanced visualization solutions. NVIDIA's CUDA parallel computing platform and AI-focused hardware, such as the Tesla and NVIDIA A100 GPUs, have made it an integral player in the AI revolution. With a relentless focus on innovation, NVIDIA continues to drive advancements in AI, machine learning, and visual computing, positioning itself at the forefront of technology's transformative potential.
GE HEALTHCARE
General Electric Company is a diversified technology and financial services company with a presence all around the world. The company provides a wide range of products, healthcare systems and pharmaceutical diagnostics equipment. Through the healthcare segment, it provides essential healthcare technologies to developed and emerging markets and has expertise in medical imaging, digital solutions, patient monitoring and diagnostics, drug discovery, and performance improvement solutions.
In addition, the company serves customers in over 175 countries, and manufacturing and service operations are carried out at 71 manufacturing plants located in 26 states in the United States. In 2021, the company will invest US$ 1 billion in R&D and product development. The company has about 168,000 employees in 170+ countries. The company has over 4 million dollars' worth of installed base equipment. GE Healthcare serves over 1 billion patients per year and has over 200 imaging software applications.
AstraZeneca Corporation
AstraZeneca Plc. was established in 1999 and is headquartered at Cambridge, England, UK. It is a global, innovation-driven biopharmaceutical company dedicated to discovering, developing, and commercializing prescription medicines. The company operates through two segments such as clinical trial and healthcare. The company offers three main therapy units including oncology, respiratory and autoimmunity, cardiovascular & metabolic disease. Its healthcare segment engages in the manufacture and sale of pharmaceutical products. The clinical trial segment offers clinical trial services on pharmaceutical products to its group companies. It occurs in over seven areas of healthcare including infection, oncology, diabetes, local anesthesia, and maternal healthcare. The company also provides medicines for infection & vaccines, neuroscience, inflammatory & autoimmunity diseases, and eosinophil-driven diseases (EDDs) through collaboration with other companies. AstraZeneca has assembled a global coalition of partners, collaborators, and funders to rapidly advance the development of medicines. The company’s development pipeline includes 34 projects in Phase I, 50 projects in Phase II, 27 projects in late-stage development, and 56 projects in life-cycle management projects. There are 66,000 employees working in AstraZeneca across Europe, Asia, the US, Africa etc. It has about 29 industrial Sites in 19 countries.
IBM Corporation is a multinational technology company that offers a wide range of products and services in the information technology and computing fields. Furthermore, IBM is renowned for its innovation and leadership in various technology domains, including cloud computing, artificial intelligence, quantum computing, and data analytics. The company operates in multiple segments, offering a diverse range of products and services. IBM's cloud and cognitive software segment includes solutions for hybrid cloud management, data, and AI platforms, and blockchain technologies. IBM Cloud, powered by Red Hat, is a major player in the cloud computing industry, providing businesses with the flexibility and scalability needed to modernize their IT infrastructure. IBM has a global presence with operations in more than 175 countries. It serves clients ranging from small businesses to large enterprises and governments worldwide.
Intel Corporation was founded in 1968, and headquartered is located at Santa Clara, California, U.S. It is a multinational company with an international operation that designs, manufactures, and sells computer components and related products. The company designs and manufactures computing and communication components, such as microprocessors, chipsets, motherboards, and wireless and wired connectivity products. The company develops advanced integrated digital technology products, primarily integrated circuits, for industries such as computing and communications.
The company is a global technology giant headquartered in Redmond, Washington. Established in 1975 by Bill Gates and Paul Allen, the company has grown to become one of the world's leading technology firms, known for its contributions to software, hardware, cloud computing, and AI. With a mission to empower every person and organization on the planet to achieve more, Microsoft's impact on the global technology landscape is profound. At its core, Microsoft is a software company with a rich history in operating systems. The company's flagship product, Microsoft Windows, has been a dominant force in the personal computing industry for decades. Windows operates on a wide range of devices, from traditional PCs and laptops to tablets, smartphones, and servers. The Microsoft Office suite, including applications like Word, Excel, and PowerPoint, has become an industry standard for productivity software used by businesses, educational institutions, and individuals worldwide.
Sanofi
Sanofi is a global life sciences company dedicated to improving access to healthcare and supporting the people they serve throughout the continuum of care. The company operates through three business segments: pharmaceuticals, human vaccines (vaccines), and others. The pharmaceuticals segment comprises the commercial operations of various franchises, including specialty care (rare diseases, multiple sclerosis, and oncology), diabetes and cardiovascular, established prescription products, consumer healthcare and generics, and research and development, production, and marketing activities for all the company's pharmaceuticals operations. Its vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production, and marketing activities for the Company's vaccines operations. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions, and consumer healthcare. The company has increased its R&D productivity and has returned to constantly launching a high quantity of innovative medicines.
Related Reports
Oncology Precision Medicine Market
Precision Medicine Diagnostics Market
Precision Medicine Market
